HOGA1
4-hydroxy-2-oxoglutarate aldolase, mitochondrial
Also known as: C10orf65, DHDPS2, DHDPSL, FLJ37472, HOGA1_HUMAN, NPL2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86XE5
- Gene
- HOGA1
- Ensembl
- ENSG00000241935
- Chromosome
- 10
- Canonical length
- 327 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The authors of PMID:20797690 cloned this gene while searching for genes in a region of chromosome 10 linked to primary hyperoxalurea type III. They noted that even though the encoded protein has been described as a mitochondrial dihydrodipicolinate synthase-like enzyme, it shares little homology with E. coli dihydrodipicolinate synthase (Dhdps), particularly in the putative substrate-binding region. Moreover, neither lysine biosynthesis nor sialic acid metabolism, for which Dhdps is responsible, occurs in vertebrate mitochondria. They propose that this gene encodes mitochondrial 4-hydroxyl-2-oxoglutarate aldolase (EC 4.1.3.16), which catalyzes the final step in the metabolic pathway of hydroxyproline, releasing glyoxylate and pyruvate. This gene is predominantly expressed in the liver and kidney, and mutations in this gene are found in patients with primary hyperoxalurea type III. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
327 residues, UniProt reviewed canonical sequence.
>Q86XE5|HOGA1
1 MLGPQVWSSV RQGLSRSLSR NVGVWASGEG KKVDIAGIYP PVTTPFTATA EVDYGKLEEN
61 LHKLGTFPFR GFVVQGSNGE FPFLTSSERL EVVSRVRQAM PKNRLLLAGS GCESTQATVE
121 MTVSMAQVGA DAAMVVTPCY YRGRMSSAAL IHHYTKVADL SPIPVVLYSV PANTGLDLPV
181 DAVVTLSQHP NIVGMKDSGG DVTRIGLIVH KTRKQDFQVL AGSAGFLMAS YALGAVGGVC
241 ALANVLGAQV CQLERLCCTG QWEDAQKLQH RLIEPNAAVT RRFGIPGLKK IMDWFGYYGG
301 PCRAPLQELS PAEEEALRMD FTSNGWLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HOGA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- liver: 54 nTPM
- kidney: 48 nTPM
- heart muscle: 20 nTPM
- choroid plexus: 16 nTPM
- pancreas: 14 nTPM
- tongue: 11 nTPM
Single-cell type
- choroid plexus epithelial cells: 72 nCPM
- ependymal cells: 39 nCPM
- bergmann glia: 37 nCPM
- astrocytes: 23 nCPM
- oligodendrocytes: 15 nCPM
- late spermatids: 15 nCPM
Immune cell
- neutrophil: 0.8 nTPM
- basophil: 0.5 nTPM
- naive B-cell: 0.3 nTPM
- plasmacytoid DC: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- eosinophil: 0.2 nTPM
Brain region
- choroid plexus: 24 nTPM
- white matter: 22 nTPM
- cerebellum: 20 nTPM
- midbrain: 20 nTPM
- medulla oblongata: 18 nTPM
- pons: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HOGA1.
Disease | AllUniProt
Conditions HOGA1 is implicated in, by any mechanism.
- Hyperoxaluria primary 3 (HP3) MIM:613616
Disease | GeneticClinVar
141 pathogenic / likely-pathogenic of 584 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Primary hyperoxaluria type 3
- HOGA1-related disorder
- Familial cancer of breast
- Colon adenocarcinoma
- Ovarian serous cystadenocarcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.77
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.28
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glyoxylate catabolic process
- glyoxylate metabolic process
- pyruvate biosynthetic process
- trans-4-hydroxy-L-proline catabolic process
- oxalate metabolic process
Molecular functions
- protein homodimerization activity
- (4S)-4-hydroxy-2-oxoglutarate aldolase activity
- (R,S)-4-hydroxy-2-oxoglutarate aldolase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DapA-like
- Aldolase-type TIM barrel
- Dihydrodipicolinate synthetase family
- Schiff base-forming aldolase, active site
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HOGA1 as an antibody target. Whether an autoantibody or antibody against HOGA1 could matter depends on whether native HOGA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HOGA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HOGA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...